HIV Vaccine Trial in Africa Halted After Disappointing Data
A trial of an experimental HIV vaccine stopped early after preliminary data suggested it would not be effective in preventing infection, according to the trial's chief investigator.
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A trial of an experimental HIV vaccine stopped early after preliminary data suggested it would not be effective in preventing infection, according to the trial's chief investigator.
By Sabela Ojea Shares of Anixa Biosciences climbed 14% to $4.47 in after-hours trading after the company presented positive results regarding its Phase 1...
"A significant wave [of JN.1] has started here and could be blunted with a high booster rate and mitigation measures."
COVID-19 appears to be heading for a holiday season increase across most of the United States.
Researchers suggest this provides further evidence of benefit of SARS-CoV-2 vaccination before or during pregnancy.